Company Filing History:
Years Active: 2006
Title: The Innovative Contributions of Kerry A Parker
Introduction
Kerry A Parker is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that modulate chemokine receptor activity. His work is crucial in the fight against HIV and related diseases.
Latest Patents
Kerry A Parker holds a patent for "Cyclopentyl modulators of chemokine receptor activity." This patent describes cyclopentyl compounds of Formula (I) that serve as modulators of chemokine receptor activity. The compounds, along with their pharmaceutically acceptable salts and individual diastereomers, are useful in the treatment and prevention of HIV infection, delaying the onset of AIDS, and treating AIDS itself. Additionally, these compounds have potential applications in treating other diseases mediated by chemokine receptors. He has 1 patent to his name.
Career Highlights
Kerry A Parker is associated with Merck & Company, Inc., a leading global healthcare company. His role at Merck has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Paul E Finke and Jennifer L Loebach, who have collaborated with him on various projects within the company.
Conclusion
Kerry A Parker's innovative work in developing chemokine receptor modulators highlights his significant impact on medical science and the ongoing battle against HIV and related conditions. His contributions continue to pave the way for advancements in treatment options.